AlphAIalphai — Financial news for AI agents
Stock TitanMAY 112 min read$ATEC

Alphatec (ATEC) director Keith Valentine adds 135,000 shares

Alphatec Holdings, Inc. director Keith Valentine purchased 135,000 shares of common stock in open-market transactions between May 7 and May 11, 2026, increasing his direct holdings to 232,271 shares. The shares were bought at weighted average prices ranging from approximately $7.00 to $7.55 per share. This activity signals confidence from Valentine as he committed new capital at prevailing market prices.

Original reporting
Stock Titan
Published May 11, 2026, 11:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 11, 2026, 11:31 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Alphatec (ATEC) director Keith Valentine adds 135,000 shares — source image
Source · Stock Titan
Decision brief

The 30-second read

$ATECBullishMed
01

Why it matters

The recent insider purchase by Keith Valentine signals management's confidence, which could positively influence investor perception and stock performance.

02

Market read

The insider activity is relevant for investors focusing on Alphatec and the medical devices sector, indicating potential bullish sentiment.

03

What to watch

Potential overvaluation or upcoming negative news unrelated to insider activity could offset the bullish signal; consider broader fundamental analysis.

Timing: Immediate, as the insider activity occurred within the past week.

Background

Alphatec Holdings, Inc. is a medical device company specializing in spine surgery solutions.

Company-level read

Ticker impact

$ATECBullishHigh confidence
Context

The insider buying activity by Alphatec's director Keith Valentine indicates potential positive sentiment towards the company's stock.

Expected impact

Moderate upward movement in the near term (1-3 weeks).

Evidence & confidence

Insider buying, especially at elevated volumes, is often viewed as a bullish signal, reflecting management's confidence in the company's outlook.

Market effects

Sector

Potential positive impact on the medical devices and life sciences sector, indicating investor confidence in sector leaders.

Regional

Limited, as Alphatec operates primarily in the US; broader regional effects are minimal.

Global

Low, given the company's regional focus and the specific nature of insider trading activity.

Counterpoint

What could challenge this read

Insider buying can sometimes be motivated by personal reasons or other non-fundamental factors; thus, it should not be the sole basis for trading decisions.

Key entities

  • Person
    Keith Valentine

    Director of Alphatec Holdings, Inc., engaged in recent significant stock purchase.

  • Company
    Alphatec Holdings, Inc.

    Medical device company focusing on spine surgery solutions.

Read at source← All news

Related articles

AUG 6
$ATECMed

Alphatec Holdings, Inc. Q2 2026 Earnings Call Summary

Alphatec Holdings (ATEC) reported Q2 2026 results driven by 24% growth in new surgeon adoption and 20% procedural volume growth, lifting revenue 15%. Management kept full-year surgical revenue guidance at $805M and raised adjusted EBITDA guidance to $140M. It expects Q3 free cash flow of $4M to $6M and cites margin gains from inventory and supply chain efficiency.

yahoo.com6 min
AUG 4
$ATECMed

Alphatec Holdings, Inc. (ATEC): Results of Operations and Financial Condition

Alphatec Holdings, Inc. (ATEC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 atec-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 ATEC Reports Second Quarter Financial Results Total revenue of $214 million, up 15% year-over-year Surgical revenue of $196 million increased 17%, driven by 20% case volume growth Company reaffirms 2026 revenue outlook CARLSB

SEC EDGAR 8-K6 min
JUN 1
$ATECMedAI 8/10

Here is Why Alphatec (ATEC) is One of the Best Cheap Stocks Under $10 to Buy in June

Alphatec Holdings (ATEC) reported Q1 2026 results on May 5, with total revenue up 14% to $192 million and surgical revenue up 17%. The company posted non-GAAP adjusted EBITDA of $21 million and said a new bank facility would cut annual interest expense by over $6 million and extend maturities to 2031. For 2026, it expects revenue of about $882 million and adjusted EBITDA of about $134 million.

finance.yahoo.com4 min
MAY 28
$ATECMed

Alphatec Holdings, Inc. (ATEC): 12 Best Future Stocks to Buy Right Now.

Alphatec Holdings (ATEC) saw two analyst price-target cuts on May 7 while ratings stayed Overweight. Barclays lowered its target to $24 from $27, citing confidence in long-term growth despite near-term operational issues. Piper Sandler cut its target to $14 from $25 after first-quarter results missed expectations due to a weak EOS quarter and softer revenue per case from product mix headwinds.

finance.yahoo.com3 min
AUG 9
$ETNMed

Eaton Gains on $7-Million Contract

Eaton (NYSE:ETN) said the U.S. Air Force Research Laboratory awarded it a $7 million, 24-month contract to use quantum computing, machine learning, and advanced visualization to improve power grid resilience and protection. The work, with Infleqtion and Penn State, targets detection and response to multiple concurrent physical and cyber threats, addressing NERC N-2 contingency requirements.

baystreet.ca3 min